Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group

Transplant Proc. 1993 Feb;25(1 Pt 1):635-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actuarial Analysis
  • Adrenal Cortex Hormones / therapeutic use
  • Azathioprine / therapeutic use
  • Biopsy
  • Cyclosporine / therapeutic use*
  • Graft Rejection / prevention & control*
  • Humans
  • Liver Transplantation / immunology*
  • Liver Transplantation / pathology
  • Muromonab-CD3 / therapeutic use
  • Tacrolimus / therapeutic use*
  • Transplantation, Homologous

Substances

  • Adrenal Cortex Hormones
  • Muromonab-CD3
  • Cyclosporine
  • Azathioprine
  • Tacrolimus